Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion

Prion

Volumn 7, Issue 5, 2013, Pages 404-411

  Elmallah, Mohammed I Y ^a,d   Borgmeyer, Uwe ^b   Betzel, Christian ^a   Redecke, Lars ^a,c  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d Helwan University   (Egypt)

Author keywords

Metal induced oxidation; Methionine oxidation; Oxidative stress; Polymorphism; Prion protein conversion

Indexed keywords

METAL; METHIONINE; MUTANT PROTEIN; OLIGOMER; PRION PROTEIN; PRION PROTEIN[121-231]; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; HUMAN; LIGHT SCATTERING; MOLECULAR DYNAMICS; MOLECULAR SIZE; NUCLEOTIDE BINDING SITE; PROTEIN FOLDING; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SULFOXIDATION;

METAL INDUCED OXIDATION; METHIONINE OXIDATION; OXIDATIVE STRESS; POLYMORPHISM; PRION PROTEIN CONVERSION;

HUMANS; METALS; METHIONINE; MUTATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRION DISEASES; PRIONS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY;

EID: 84887833637     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.26745     Document Type: Article

References (56)

1. Weissmann C. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies. FEBS Lett 1996;389:3-11; PMID:8682199; http://d x.doi.org/10.1016/0014-5793 (96) 00610-2
2. Zahn R, Liu A, Lührs T, Riek R, Von Schroetter C, López García F, Billeter M, Calzolai L, Wider G, Wüthrich K. NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A 2000;97:145-50; PMID:10618385; http://d x.doi.or g/10.1073/pn a s.97.1.145
3. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. Conversion of alpha-helices into betasheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 1993;90:10962-6; PMID:7902575; http://dx.doi.org/10.1073/pnas.90. 23.10962
4. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136-44; PMID:6801762; http://dx.doi.org/10.1126/science.6801762
5. Prusiner SB. Molecular biology of prion diseases. Science 1991;252:1515-22; PMID:1675487; http://d x.doi.org/10.1126/scienc e.1675487
6. Weissmann C, Aguzzi A. Bovine spongiform encephalopathy and early onset variant Creutzfeldt-Jakob disease. Curr Opin Neurobiol 1997;7:695-700; PM ID:9384548; http://d x.doi.org/10.1016/S0959-4388 (97) 80091-8
7. Milhavet O, Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Brain Res Rev 2002;38:328-39; PMID:11890980; http://d x.doi.org/10.1016/S0165-0173 (01) 00150-3
8. Brown DR. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. Folia Neuropathol 2005;43:229-43; PMID:16416388
9. Stadtman ER. Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci 2001;928:22-38; PMI D:11795513; http://dx.doi.org/10.1111/j.1749-6632. 2001.tb 05632.x
10. Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A 2001;98:12920-5; PMID:11606777; http://dx.doi. or g/10.1073/pn a s.231472998
11. Cui ZJ, Han ZQ, Li ZY. Modulating protein activity and cellular function by methionine residue oxidation. Amino Acids 2012;43:505-17; PMID:22146868; http://d x.doi.org/10.1007/s 00726-011-1175-9
12. Nadal RC, Abdelraheim SR, Brazier MW, Rigby SE, Brown DR, Viles JH. Prion protein does not redox-silence Cu2+, but is a sacrificial quencher of hydroxyl radicals. Free Radic Biol Med 2007;42:79-89; PMID:17157195; http://d x.d oi.org/10.1016/j.freeradbiomed.2006.09.019
13. Canello T, Engelstein R, Moshel O, Xanthopoulos K, Juanes ME, Langeveld J, Sklaviadis T, Gasset M, Gabizon R. Methionine sulfoxides on PrPSc: a prion-specific covalent signature. Biochemistry 2008;47:8866-73; PMID:18680312; http://dx.doi.org/10.1021/bi800801f
14. Silva CJ, Onisko BC, Dynin I, Erickson ML, Vensel WH, Requena JR, Antaki EM, Carter JM. Assessing the role of oxidized methionine at position 213 in the formation of prions in hamsters. Biochemistry 2010;49:1854-61; PMID:20121218; http://dx.doi.org/10.1021/bi901850 n
15. Colombo G, Meli M, Morra G, Gabizon R, Gasset M. Methionine sulfoxides on prion protein Helix-3 switch on the α-fold destabilization required for conversion. PLoS One 2009;4:e4296; PMID:19172188; http://dx.doi.org/10.1371/ journal.pone.0004296
16. De Marco ML, Daggett V. Local environmental effects on the structure of the prion protein. C R Biol 2005;328:847-62; PMID:16286076; http://dx.doi.org/ 10.1016/j.c r v i.2005.05.001
17. Lisa S, Meli M, Cabello G, Gabizon R, Colombo G, Gasset M. The structural intolerance of the PrP α-fold for polar substitution of the helix-3 methionines. Cell Mol Life Sci 2010;67:2825-38; PMID:20454997; http://dx.doi.org/10.1007/s00018-010-0363-1
18. Wolschner C, Giese A, Kretzschmar HA, Huber R, Moroder L, Budisa N. Design of anti -and proaggregation variants to assess the effects of methionine oxidation in human prion protein. Proc Natl Acad Sci U S A 2009;106:7756-61; PMID:19416900; http://d x.doi.org/10.1073/pn a s.0902688106
19. Younan ND, Nadal RC, Davies P, Brown DR, Viles JH. Methionine oxidation perturbs the structural core of the prion protein and suggests a generic misfolding pathway. J Biol Chem 2012;287:28263-75; PM ID:22654104; htt p://d x.doi.or g/10.1074/jb c. M112.354779
20. Hart T, Hosszu LL, Trevitt CR, Jackson GS, Waltho JP, Collinge J, Clarke AR. Folding kinetics of the human prion protein probed by temperature jump. Proc Natl Acad Sci U S A 2009;106:5651-6; PM ID:19321423; http://d x.doi.org/10.1073/pn a s.0811457106
21. Redecke L, Von Bergen M, Clos J, Konarev PV, Svergun DI, Fittschen UE, Broekaert JA, Bruns O, Georgieva D, Mandelkow E, et al. Structural characterization of β-sheeted oligomers formed on the pathway of oxidative prion protein aggregation in vitro. J Struct Biol 2007;157:308-20; PMID:17023178; http://dx.doi.org/10.1016/j.js b. 2006.06.013
22. Requena JR, Dimitrova MN, Legname G, Teijeira S, Prusiner SB, Levine RL. Oxidation of methionine residues in the prion protein by hydrogen peroxide. Arch Biochem Biophys 2004;432:188-95; PMID:15542057; http://dx.doi.org/10.1016/j. abb.2004.09.012
23. Wong BS, Wang H, Brown DR, Jones IM. Selective oxidation of methionine residues in prion proteins. Biochem Biophys Res Commun 1999;259:352-5; PMID:10362513; http://dx.doi.org/10.1006/bbrc.1999.0802
24. Abdelraheim SR, Královicová S, Brown DR. Hydrogen peroxide cleavage of the prion protein generates a fragment able to initiate polymerisation of full length prion protein. Int J Biochem Cell Biol 2006;38:1429-40; PMID:16595185; http://dx.doi.org/10.1016/j. biocel.2006.02.007
25. Nyström S, Mishra R, Hornemann S, Aguzzi A, Nilsson K P R, Hammarström P. Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway. J Biol Chem 2012;287:25975-84; PMID:22669942; http://d x.doi.org/10.1074/jbc. M112.372136
26. Windl O, Dempster M, Estibeiro JP, Lathe R, De Silva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KC, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 1996;98:259-64; PMID:8707291; http://dx.doi.org/10.1007/s004390050204
27. Redecke L, Binder S, Elmallah M I Y, Broadbent R, Tilkorn C, Schulz B, May P, Goos A, Eich A, Rübhausen M, et al. UV-light-induced conversion and aggregation of prion proteins. Free Radic Biol Med 2009;46:1353-61; PMID:19249347; http://dx.doi.org/10.1016/j.freeradbiomed.2009.02.013
28. Rezaei H, Eghiaian F, Perez J, Doublet B, Choiset Y, Haertle T, Grosclaude J. Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities. J Mol Biol 2005;347:665-79; PMID:15755458; http://d x.doi.org/10.1016/j.jm b. 2005.01.043
29. Jeganathan S, Hascher A, Chinnathambi S, Biernat J, Mandelkow EM, Mandelkow E. Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. J Biol Chem 2008;283:32066-76; PMID:18725412; http://dx.doi.org/10.1074/jbc. M805300200
30. Nyström S, Mishra R, Hornemann S, Aguzzi A, Nilsson K P R, Hammarström P. Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway. J Biol Chem 2012;287:25975-84; PMID:22669942; http://d x.doi.org/10.1074/jbc. M112.372136
31. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983;35:349-58; PMID:6418385; http://dx.doi. or g/10.1016/0092-8674 (83) 90168-X
32. Rehders D, Claasen B, Redecke L, Buschke A, Reibe C, Jehmlich N, Von Bergen M, Betzel C, Meyer B. Peptide NMHRYPNQ of the cellular prion protein (PrP (C)) inhibits aggregation and is a potential key for understanding prion-prion interactions. J Mol Biol 2009;392:198-207; PM ID:19607841; http://dx.doi. or g/10.1016/j.jmb. 2009.07.014
33. Caughey B, Lansbury P T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bysta nders. A nnu Rev Neurosci 2003;26:267-98; PMID:12704221; http://d x.d o i.org/10.1146/a n nu re v. ne u r o. 26. 010302. 081142
34. Simoneau S, Rezaei H, Salès N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, Fournier JG, Comte J, Wopfner F, Grosclaude J, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 2007;3:e125; PMID:17784787; http://dx.doi.org/10.1371/journal.ppat.0030125
35. Walsh DM, Selkoe DJ. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 2004;11:213-28; PMID:15182223; http://dx.doi.org/10.2174/0929866043407174
36. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003;300:486-9; PMID:12702875; http://dx.doi.org/10.1126/ science.1079469
37. Walsh DM, Klyubin I, Fadeeva J V, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002;416:535-9; PMID:11932745; http://d x.doi.org/10.1038/416535a
38. Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, Hetzer C, Loher T, Vilar M, Campioni S, et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A 2011;108:4194-9; PMID:21325059; http://dx.doi. or g/10.1073/pna s.1100976108
39. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature 2005;437:257-61; PMID:16148934; http://dx.doi.or g/10.1038/nature03989
40. Dobson CM. Protein folding and misfolding. Nature 2003;426:884-90; PMID:14685248; http://dx.doi. or g/10.1038/natu re 02261
41. Chernoff YO. Amyloidogenic domains, prions and structural inheritance: rudiments of early life or recent acquisition? Curr Opin Chem Biol 2004;8:665-71; PMID:15556413; http://dx.doi.org/10.1016/j. cbpa.2004.09.002
42. Eichner T, Radford SE. A diversity of assembly mechanisms of a generic amyloid fold. Mol Cell 2011;43:8-18; PMID:21726806; http://dx.doi.org/10.1016/j. molcel.2011.05.012
43. Wolfe KJ, Cyr DM. Amyloid in neurodegenerative diseases: friend or foe? Semin Cell Dev Biol 2011;22:476-81; PMID:21458579; http://d x.doi.org/10.1016/j. semcdb.2011.03.011
44. Duennwald ML. Polyglutamine misfolding in yeast: toxic and protective aggregation. Prion 2011;5:285-90; PMID:22052348
45. Barten DM, Albright CF. Therapeutic strategies for Alzheimer's disease. Mol Neurobiol 2008;37:171-86; PMID:18581273; http://d x.doi.org/10.1007/s12035- 008-8031-2
46. Campioni S, Mannini B, Zampagni M, Pensalfini A, Parrini C, Evangelisti E, Relini A, Stefani M, Dobson CM, Cecchi C, et al. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol 2010;6:140-7; PMID:20081829; http://dx.doi.org/10.1038/nchembio.283
47. Binger KJ, Griffin MD, Heinemann SH, Howlett GJ. Methionine-oxidized amyloid f ibrils are poor substrates for human methionine sulfoxide reductases A and B2. Biochemistry 2010;49:2981-3; PMID:20218727; http://dx.doi.org/10.1021/ bi902203m
48. O'Sullivan DB, Jones CE, Abdelraheim SR, Thompsett AR, Brazier MW, Toms H, Brown DR, Viles JH. NMR characterization of the pH 4 β-intermediate of the prion protein: the N-terminal half of the protein remains unstructured and retains a high degree of flexibility. Biochem J 2007;401:533-40; PMID:16958619; http://dx.doi.org/10.1042/BJ20060668
49. Bocharova OV, Breydo L, Salnikov V V, Baskakov IV. Copper (II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry 2005;44:6776-87; PMID:15865423; http://dx.doi.org/10.1021/bi050251q
50. Sun Y, Breydo L, Makarava N, Yang Q, Bocharova OV, Baskakov I V. Site-specific conformational studies of prion protein (PrP) amyloid fibrils revealed two cooperative folding domains within amyloid structure. J Biol Chem 2007;282:9090-7; PMID:17244617; http://dx.doi.org/10.1074/jbc. M608623200
51. Alonso DO, De Armond SJ, Cohen FE, Daggett V. Mapping the early steps in the pH-induced conformational conversion of the prion protein. Proc Natl Acad Sci U S A 2001;98:2985-9; PMI D:11248018; http://d x.doi.or g/10.1073/pna s.061555898
52. Kaimann T, Metzger S, Kuhlmann K, Brandt B, Birkmann E, Höltje HD, Riesner D. Molecular model of an α-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations. J Mol Biol 2008;376:582-96; PMID:18158160; http://dx.doi.org/10. 1016/j.jmb.2007.11.035
53. Sideri TC, Koloteva-Levine N, Tuite MF, Grant CM. Methionine oxidation of Sup35 protein induces formation of the [PSI+] prion in a yeast peroxiredoxin mutant. J Biol Chem 2011;286:38924-31; PMID:21832086; http://dx.doi.org/10.1074/ jbc. M111.272419
54. Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA, Perry G, Carey PR. Metal binding and oxidation of amyloid-β within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 2003;42:2768-73; PMID:12627941; http://dx.doi.org/10.1021/bi0272151
55. Yamin G, Glaser CB, Uversky VN, Fink AL. Certain metals trigger fibrillation of methionine-oxidized α-synuclein. J Biol Chem 2003;278:27630-5; PMID:12754258; http://d x.doi.org/10.1074/jbc. M303302200
56. Georgieva D, Koker M, Redecke L, Perbandt M, Clos J, Bredehorst R, Genov N, Betzel C. Oligomerization of the proteolytic products is an intrinsic property of prion proteins. Biochem Biophys Res Commun 2004;323:1278-86; PMID:15451435; http://dx.doi.org/10.1016/j.bbrc.2004.08.230